These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway. Palmqvist P, Lundberg P, Persson E, Johansson A, Lundgren I, Lie A, Conaway HH, Lerner UH. J Biol Chem; 2006 Feb 03; 281(5):2414-29. PubMed ID: 16251181 [Abstract] [Full Text] [Related]
23. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells. Poulsen RC, Wolber FM, Moughan PJ, Kruger MC. Prostaglandins Other Lipid Mediat; 2008 Feb 03; 85(1-2):42-8. PubMed ID: 18077200 [Abstract] [Full Text] [Related]
25. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. Ozaki Y, Koide M, Furuya Y, Ninomiya T, Yasuda H, Nakamura M, Kobayashi Y, Takahashi N, Yoshinari N, Udagawa N. PLoS One; 2017 Feb 03; 12(9):e0184904. PubMed ID: 28937990 [Abstract] [Full Text] [Related]
28. The role of polyunsaturated ω-3 fatty acid eicosapentaenoic acid-derived resolvin E1 (RvE1) in bone preservation. Gyurko R, Van Dyke TE. Crit Rev Immunol; 2014 Feb 03; 34(4):347-57. PubMed ID: 24941160 [Abstract] [Full Text] [Related]
29. Osteoprotective effects of osthole in a mouse model of 5/6 nephrectomy through inhibiting osteoclast formation. Li X, Xue C, Wang L, Tang D, Huang J, Zhao Y, Chen Y, Zhao D, Shi Q, Wang Y, Shu B. Mol Med Rep; 2016 Oct 03; 14(4):3769-76. PubMed ID: 27571745 [Abstract] [Full Text] [Related]
33. Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis. Mediero A, Wilder T, Shah L, Cronstein BN. FASEB J; 2018 Jul 03; 32(7):3487-3501. PubMed ID: 29394106 [Abstract] [Full Text] [Related]
34. Overloaded Orthopedic Force Induces Condylar Subchondral Bone Absorption by Stimulating Rat Mesenchymal Stem Cells Differentiating into Osteoclasts via mTOR-Regulated RANKL/OPG Secretion in Osteoblasts. Tian Y, Chen J, Yan X, Ren D, Liu M, Zhang Q, Zhang Q, Yuan X. Stem Cells Dev; 2021 Jan 01; 30(1):29-38. PubMed ID: 33176606 [Abstract] [Full Text] [Related]
35. Cabozantinib targets bone microenvironment modulating human osteoclast and osteoblast functions. Fioramonti M, Santini D, Iuliani M, Ribelli G, Manca P, Papapietro N, Spiezia F, Vincenzi B, Denaro V, Russo A, Tonini G, Pantano F. Oncotarget; 2017 Mar 21; 8(12):20113-20121. PubMed ID: 28223547 [Abstract] [Full Text] [Related]
36. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro. Ming LG, Lv X, Ma XN, Ge BF, Zhen P, Song P, Zhou J, Ma HP, Xian CJ, Chen KM. Endocrinology; 2013 Mar 21; 154(3):1202-14. PubMed ID: 23389955 [Abstract] [Full Text] [Related]
37. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. Kitamura K, Takahira K, Inari M, Satoh Y, Hayakawa K, Tabuchi Y, Ogai K, Nishiuchi T, Kondo T, Mikuni-Takagaki Y, Chen W, Hattori A, Suzuki N. Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep 21; 166(1):74-80. PubMed ID: 23632157 [Abstract] [Full Text] [Related]